What does Overture Life do?
Overture Life specializes in embryology lab procedures, integrating engineering, robotics, analytics, and clinical rigor to modernize egg freezing and embryo handling. Its focus is on creating reproducible and efficient IVF lab processes to improve patient outcomes.
How much did they raise?
The company raised $20.6M in a funding round, with lead investors including Khosla Ventures, Overwater Ventures, and GV. This round brings the total funding for Overture Life to $57M.
What are their plans for the money?
With the new capital, Overture Life aims to expand fertility access globally by refining its automated IVF lab procedures and advancing innovative solutions like its AI-powered, non-invasive metabolomic test. The investment will further support research and expansion of their clinical operations in the United States and Spain.
What have they achieved so far?
Overture Life has already made significant strides, including the launch of its DaVitri platform that improves the reliability and consistency of IVF procedures, and achieving a CLIA license in the United States, meeting strict federal clinical laboratory standards.
